Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seviteronel in advanced breast cancer
NCT02580448Phase 2Completed
- Sponsor
- Innocrin
- Start
- Aug 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seviteronel in breast cancer, sponsored by Innocrin. Started Aug 2015; status: completed.
02
Drugs
seviteronel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02580448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580448.